Estée Lauder to cut up to 7,000 jobs as it swings to loss, sending stock lower

• AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%

  AbbVie’s earnings topped estimates, and it offered an upbeat view of 2025.
  
  MarketWatch - 3d

• Chevron logs its first refining loss in four years, sending stock lower

  Chevron touted “record production” as well as stock buybacks and announced an increase in its quarterly dividend.
  
  MarketWatch - 3d

• Dow to cut 1,500 jobs as it struggles to restore profitability. Stock slides to four-year low

  The company is also optimistic that it will see demand growth in certain markets.
  
  MarketWatch - 4d

• Whirlpool swings to a loss and guides for more weakness in 2025, sending stock down

  Appliance maker is still working to cut costs and hoping for a recovery in the U.S. housing market.
  
  MarketWatch - 5d
• 

  Adidas to cut up to 500 jobs after posting better-than-expected holiday profits

  Adidas plans to cut as many as 500 jobs in a bid to simplify its business, a person familiar with the matter confirmed to CNBC on Thursday.
  
  NBC News - Jan. 24

• Adidas to cut up to 500 jobs after posting better-than-expected holiday profits

  Adidas plans to cut as many as 500 jobs at its corporate headquarters in Germany in a bid to simplify its business—not to cut costs.
  
  CNBC - Jan. 23
• 

  Medicare to Negotiate Lower Prices for Weight-Loss Drugs

  The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
  
  The New York Times - Jan. 17

• IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out, sending stock down 69%

  IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.
  
  MarketWatch - Jan. 10
• 

  Lloyds Banking Group’s branch shake-up fuels concern over closures and job cuts

  Company’s customers across Halifax, Bank of Scotland and flagship brand to be allowed to use others’ premises
  
  Financial Times - Jan. 8

More from MarketWatch

• One Palantir bear waves a white flag after earnings beat. Many remain.

  Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren’t quite ready to call it a buy either.
  
  MarketWatch - 17m

• Ferrari offers cautious guidance. The stock revs higher anyway.

  Sports-car maker Ferrari reported a jump in fourth-quarter profit, buoyed by product mix even as shipments grew just 2%.
  
  MarketWatch - 34m

• The tariff wars aren’t over. China hits back over new 10% tariffs.

  U.S. agreements with Canada and Mexico stopped tariffs before they were to enter into effect, but the trade war between the world’s top two economies is continuing.
  
  MarketWatch - 41m

• Cyber cop specialist SailPoint eyes $1 billion in proceeds in IPO return

  Private-equity firm Thoma Bravo taking company public at an estimated market cap of $11 billion in its return to the stock market
  
  MarketWatch - 56m

• Merck’s soft guidance overshadows quarterly beat to send stock down 8%

  Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.
  
  MarketWatch - 1h

More in Business

• Palantir soars more than 23% as AI powers strong earnings and guidance

  Palantir surged more than 23% in premarket trading on robust fourth-quarter results and guidance.
  
  CNBC - 9m

• McDonald's Shamrock Shake returns — and so does Grimace's uncle

  McDonald's is bringing back the mascot Uncle O'Grimacey, Grimace's uncle, to promote the seasonal milkshake.
  
  CNBC - 13m

• Jim Cramer's top 10 things to watch in the stock market Tuesday

  China announcing retaliatory trade tariffs against the U.S. pressured Wall Street ahead of Tuesday's open.
  
  CNBC - 15m

• PayPal shares slip as growth slows in card processing

  PayPal reported better-than-expected fourth-quarter earnings and revenue in its quarterly report on Tuesday.
  
  CNBC - 16m

• One Palantir bear waves a white flag after earnings beat. Many remain.

  Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren’t quite ready to call it a buy either.
  
  MarketWatch - 17m